{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:29Z","timestamp":1790959289416,"version":"4.1.0"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.arr.2022.101654","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T21:54:51Z","timestamp":1653688491000},"page":"101654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["A new generation of AD biomarkers: 2019 to 2021"],"prefix":"10.1016","volume":"79","author":[{"given":"Jade","family":"Hawksworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2021-000143","article-title":"Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis","volume":"3","author":"Alagaratnam","year":"2021","journal-title":"BMJ Neurol. Open"},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer\u2019s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2022.101654_bib4","article-title":"2020 Alzheimer\u2019s disease facts and figures","author":"Alzheimer\u2019s Association","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101654_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0404.107.s179.9.x","article-title":"Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"179","author":"Andreasen","year":"2003","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.arr.2022.101654_bib6","article-title":"Soluble APP-\u03b1 and APP-\u03b2 in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment","author":"Araki","year":"2021","journal-title":"Aging Clin. Exp. Res"},{"issue":"11","key":"10.1016\/j.arr.2022.101654_bib7","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41380-019-0410-8","article-title":"Familial Alzheimer\u2019s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta","volume":"25","author":"Arber","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib9","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00259-021-05253-y","article-title":"The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers","volume":"48","author":"Ashton","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib10","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JAD-200755","article-title":"Plasma glial fibrillary acidic protein levels differ along the spectra of amyloid burden and clinical disease stage","volume":"78","author":"Asken","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101654_bib12","first-page":"1","article-title":"Lower white matter volume and worse executive functioning reflected in higher levels of plasma GFAP among older adults with and without cognitive impairment","author":"Asken","year":"2021","journal-title":"J. Int Neuropsychol. Soc."},{"key":"10.1016\/j.arr.2022.101654_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer\u2019s disease","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2022.101654_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101904","article-title":"Acute phase markers in CSF reveal inflammatory changes in Alzheimer\u2019s disease that intersect with pathology, APOE \u03b54, sex and age","volume":"198","author":"Ayton","year":"2021","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.arr.2022.101654_bib15","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199356","article-title":"Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease","volume":"16","author":"Bader","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/15672050113109990138","article-title":"BACE1 levels correlate with phospho-tau levels in human cerebrospinal fluid","volume":"10","author":"Barao","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"12","key":"10.1016\/j.arr.2022.101654_bib17","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1093\/brain\/awaa342","article-title":"Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease","volume":"143","author":"Benedet","year":"2020","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/acn3.51402","article-title":"Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer\u2019s disease","volume":"8","author":"Bergstr\u00f6m","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0896-6273(93)90279-Z","article-title":"Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding","volume":"11","author":"Biernat","year":"1993","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/WAD.0b013e3181a6bebc","article-title":"Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors","volume":"23","author":"Bradford","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2022.101654_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1750-1326-9-53","article-title":"SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer\u2019s disease","volume":"9","author":"Brinkmalm","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-017-0293-3","article-title":"Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer\u2019s disease","volume":"9","author":"Brody","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"Pt 11","key":"10.1016\/j.arr.2022.101654_bib23","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.arr.2022.101654_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.exger.2009.06.003","article-title":"Validation of Alzheimer\u2019s disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer\u2019s Disease Neuroimaging Initiative (E-ADNI)","volume":"44","author":"Buerger","year":"2009","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.arr.2022.101654_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neurobiolaging.2021.02.008","article-title":"Cognitively normal APOE \u03b54 carriers have specific elevation of CSF SNAP-25","volume":"102","author":"Butt","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13195-020-00711-5","article-title":"Prediction of Alzheimer\u2019s disease biomarker status defined by the \u2018ATN framework\u2019 among cognitively healthy individuals: results from the EPAD longitudinal cohort study","volume":"12","author":"Calvin","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14789450.2021.1886929","article-title":"Progress regarding the context-of-use of tau as biomarker of Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"18","author":"Campese","year":"2021","journal-title":"Expert Rev. Proteom."},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052761","article-title":"Machine learning and novel biomarkers for the diagnosis of Alzheimer\u2019s disease","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41398-021-01476-7","article-title":"Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer\u2019s disease","volume":"11","author":"Chen","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib31","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1038\/s41598-019-50315-9","article-title":"Plasma A\u03b242 and total tau predict cognitive decline in amnestic mild cognitive impairment","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"issue":"3\u20134","key":"10.1016\/j.arr.2022.101654_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000505435","article-title":"Changes in plasma amyloid and tau in a longitudinal study of normal aging, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"48","author":"Chen","year":"2019","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2022.101654_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101446","article-title":"Diagnostic accuracy of blood biomarkers for Alzheimer\u2019s disease and amnestic mild cognitive impairment: a meta-analysis","volume":"71","author":"Chen","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jalz.2018.09.010","article-title":"Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease","volume":"15","author":"Chen","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib35","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1038\/s41467-020-19543-w","article-title":"Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals","volume":"11","author":"Chhatwal","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.arr.2022.101654_bib36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/jnnp-2021-327370","article-title":"Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer\u2019s disease: a focused review on recent advances","volume":"92","author":"Chong","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-018-1948-2","article-title":"Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer\u2019s disease","volume":"137","author":"Cicognola","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13195-020-00756-6","article-title":"Cerebrospinal fluid N-224 tau helps discriminate Alzheimer\u2019s disease from subjective cognitive decline and other dementias","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13195-021-00805-8","article-title":"Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer\u2019s disease pathology and clinical disease progression","volume":"13","author":"Clark","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-021-00814-7","article-title":"An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer\u2019s disease","volume":"13","author":"Clark","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-019-0564-2","article-title":"CSF synaptic protein concentrations are raised in those with atypical Alzheimer\u2019s disease but not frontotemporal dementia","volume":"11","author":"Clarke","year":"2019","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib43","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1523\/JNEUROSCI.19-03-00928.1999","article-title":"Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins","volume":"19","author":"Combs","year":"1999","journal-title":"J. Neurosci."},{"issue":"5123","key":"10.1016\/j.arr.2022.101654_bib44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.arr.2022.101654_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s43587-020-00003-5","article-title":"Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations","author":"Cullen","year":"2020","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib46","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/s41598-021-81705-7","article-title":"Accelerated inflammatory aging in Alzheimer\u2019s disease and its relation to amyloid, tau, and cognition","volume":"11","author":"Cullen","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib47","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41467-021-23746-0","article-title":"Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations","volume":"12","author":"Cullen","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00001756-200204160-00015","article-title":"Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients","volume":"13","author":"Davidsson","year":"2002","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","article-title":"A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer\u2019s disease","volume":"78","author":"Davies","year":"1987","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.arr.2022.101654_bib50","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jalz.2015.05.012","article-title":"C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease","volume":"11","author":"De Vos","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13195-021-00817-4","article-title":"Prognostic value of amyloid\/tau\/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer\u2019s disease","volume":"13","author":"Delmotte","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2022.101654_bib53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2022.101654_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12014-019-9237-1","article-title":"Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer\u2019s disease","volume":"16","author":"Dey","year":"2019","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.arr.2022.101654_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104810","article-title":"Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying \u03b2-amyloid pathology","volume":"139","author":"Diouf","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3233\/JAD-150692","article-title":"Timely diagnosis for Alzheimer\u2019s disease: a literature review on benefits and challenges","volume":"49","author":"Dubois","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.arr.2022.101654_bib57","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jalz.2013.12.023","article-title":"The cerebrospinal fluid \"Alzheimer profile\": easily said, but what does it mean?","volume":"10","author":"Duits","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.arr.2022.101654_bib58","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","article-title":"Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease","volume":"26","author":"Dujardin","year":"2020","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.arr.2022.101654_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10143009","article-title":"Fatty acid binding protein 3 (FABP3) and apolipoprotein E4 (ApoE4) as lipid metabolism-related biomarkers of Alzheimer\u2019s disease","volume":"10","author":"Dulewicz","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2022.101654_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2021.07.003","article-title":"Proteomic correlates of cortical thickness in cognitively normal individuals with normal and abnormal cerebrospinal fluid beta-amyloid","volume":"107","author":"Ekblad","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib61","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","article-title":"Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease","volume":"16","author":"Elahi","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-190426","article-title":"Tip of the iceberg: assessing the global socioeconomic costs of Alzheimer\u2019s disease and related dementias and strategic implications for stakeholders","volume":"70","author":"El-Hayek","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101654_bib63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnmol.2017.00056","article-title":"Regulation of alpha-secretase ADAM10","volume":"10","author":"Endres","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"226","key":"10.1016\/j.arr.2022.101654_bib64","doi-asserted-by":"crossref","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2022.101654_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116662","article-title":"Mixed dementia: Neglected clinical entity or nosographic artifice?","volume":"410","author":"Fierini","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\". a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.arr.2022.101654_bib67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.dadm.2019.05.001","article-title":"Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer\u2019s disease","volume":"11","author":"Fossati","year":"2019","journal-title":"Alzheimers Dement (Amst.)"},{"issue":"6","key":"10.1016\/j.arr.2022.101654_bib68","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.arr.2022.101654_bib69","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.arr.2022.101654_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081930","article-title":"Neuroinflammation and Alzheimer\u2019s disease: a machine learning approach to CSF proteomics","volume":"10","author":"Gaetani","year":"2021","journal-title":"Cells"},{"issue":"6420","key":"10.1016\/j.arr.2022.101654_bib71","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.aau0437","article-title":"Alzheimer's disease: The right drug, the right time","volume":"362","author":"Golde","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib72","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/WAD.0b013e31827b60d2","article-title":"Plasma proteomics for the identification of Alzheimer disease","volume":"27","author":"Guo","year":"2013","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib73","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13195-015-0105-6","article-title":"Follow-up plasma apolipoprotein E levels in the Australian Imaging, biomarkers and lifestyle flagship study of ageing (AIBL) cohort","volume":"7","author":"Gupta","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2022.101654_bib74","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-associated astrocytes in Alzheimer\u2019s disease and aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.arr.2022.101654_bib75","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-Secretase BACE1 in Alzheimer\u2019s disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib76","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.arr.2022.101654_bib77","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharm. Sci."},{"issue":"5054","key":"10.1016\/j.arr.2022.101654_bib78","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib79","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"43","key":"10.1016\/j.arr.2022.101654_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz9360","article-title":"Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease","volume":"6","author":"Higginbotham","year":"2020","journal-title":"Sci. Adv."},{"issue":"6286","key":"10.1016\/j.arr.2022.101654_bib81","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.arr.2022.101654_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12330","article-title":"TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels","author":"Hong","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.arr.2022.101654_bib84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.lfs.2018.08.019","article-title":"Dickkopf-1: current knowledge and related diseases","volume":"209","author":"Huang","year":"2018","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib85","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1212\/WNL.0000000000011226","article-title":"Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease","volume":"96","author":"Ill\u00e1n-Gala","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101654_bib86","series-title":"World Alzheimer Report 2019: Attitudes to Dementia","author":"International, Alzheimer\u2019s Disease","year":"2019"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib87","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-180970","article-title":"Identification and preliminary validation of a plasma profile associated with cognitive decline in dementia and at-risk individuals: a retrospective cohort analysis","volume":"67","author":"Iulita","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib88","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/acn3.266","article-title":"Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer\u2019s disease","volume":"3","author":"Janelidze","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib90","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2022.101654_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/alz.052117","article-title":"Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma A\u03b242\/A\u03b240 and p-tau","author":"Janelidze","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of plasma Phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41398-021-01206-z","article-title":"Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer\u2019s disease","volume":"11","author":"Johansson","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib94","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med"},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib95","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2967\/jnumed.113.120618","article-title":"Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association","volume":"54","author":"Johnson","year":"2013","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib96","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/alz.12236","article-title":"Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis","volume":"17","author":"Karikari","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib97","first-page":"434","article-title":"Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70","volume":"144","author":"Keshavan","year":"2021","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.arr.2022.101654_bib98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib99","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3233\/JAD-143018","article-title":"Elevation of the plasma A\u03b240\/A\u03b242 ratio as a diagnostic marker of sporadic early-onset Alzheimer\u2019s Disease","volume":"48","author":"Kim","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101654_bib100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N.Y.)"},{"issue":"36","key":"10.1016\/j.arr.2022.101654_bib101","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","article-title":"Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines","volume":"25","author":"Koenigsknecht-Talboo","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2022.101654_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.15465","article-title":"Mass spectrometry-based methods for robust measurement of Alzheimer\u2019s Disease biomarkers in biological fluids","author":"Korecka","year":"2021","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-200900","article-title":"Blood-Based ATN biomarkers of Alzheimer\u2019s disease: a meta-analysis","volume":"79","author":"Koychev","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060921","article-title":"Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology","volume":"8","author":"Krabbe","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-015-0124-3","article-title":"Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer\u2019s disease patients and healthy controls","volume":"7","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Res. Ther."},{"issue":"10","key":"10.1016\/j.arr.2022.101654_bib106","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease","volume":"11","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib107","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1084\/jem.20181035","article-title":"3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice","volume":"216","author":"Lazic","year":"2019","journal-title":"J. Exp. Med"},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib108","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00259-021-05258-7","article-title":"2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"48","author":"Leuzy","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib109","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1532-5415.2010.02906.x","article-title":"Age-varying association between statin use and incident Alzheimer\u2019s disease","volume":"58","author":"Li","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2022.101654_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.670115","article-title":"Better identification of cognitive decline with Interleukin-2 than with amyloid and Tau protein biomarkers in amnestic mild cognitive impairment","volume":"13","author":"Liang","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2022.101654_bib111","author":"Libiger","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.arr.2022.101654_bib112","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1515\/cclm-2019-0428","article-title":"Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer\u2019s disease","volume":"57","author":"Lim","year":"2019","journal-title":"Clin. Chem. Lab Med."},{"issue":"10113","key":"10.1016\/j.arr.2022.101654_bib113","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib114","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","article-title":"Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer\u2019s disease cerebrospinal fluid","volume":"18","author":"Lle\u00f3","year":"2019","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.arr.2022.101654_bib115","first-page":"CD009628","article-title":"Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer\u2019s disease in people with mild cognitive impairment","volume":"3","author":"Lombardi","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.arr.2022.101654_bib116","unstructured":"Lopez, M.J., A. Royer, and N.J. Shah. 2020. \"Ceruloplasmin.\" In Biochemistry. StatPearls Publishing."},{"key":"10.1016\/j.arr.2022.101654_bib117","doi-asserted-by":"crossref","first-page":"11161","DOI":"10.1038\/srep11161","article-title":"Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody","volume":"5","author":"Luo","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib118","doi-asserted-by":"crossref","first-page":"9277","DOI":"10.18632\/aging.202950","volume":"13","author":"Madrid","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"30","key":"10.1016\/j.arr.2022.101654_bib119","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","article-title":"Mechanisms underlying the rapid peroxisome proliferator-activated receptor-\u03b3-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer\u2019s disease","volume":"32","author":"Mandrekar-Colucci","year":"2012","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.arr.2022.101654_bib121","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib122","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/13607863.2018.1544208","article-title":"Caregivers\u2019 emotional distress due to neuropsychiatric symptoms of persons with amnestic mild cognitive impairment or Alzheimer\u2019s disease","volume":"24","author":"Mavounza","year":"2020","journal-title":"Aging Ment. Health"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40520-019-01458-2","article-title":"A meta-analysis on the levels of VILIP-1 in the CSF of Alzheimer\u2019s disease compared to normal controls and other neurodegenerative conditions","volume":"33","author":"Mavroudis","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"issue":"6523","key":"10.1016\/j.arr.2022.101654_bib124","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/374647a0","article-title":"Activation of microglial cells by beta-amyloid protein and interferon-gamma","volume":"374","author":"Meda","year":"1995","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.arr.2022.101654_bib125","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1074\/mcp.TIR118.000900","article-title":"Online parallel accumulation-serial fragmentation (PASEF) with a novel trapped ion mobility mass spectrometer","volume":"17","author":"Meier","year":"2018","journal-title":"Mol. Cell Proteom."},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib126","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-5793(98)00234-8","article-title":"Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer\u2019s patients: relation with the senile plaques and cytoskeleton biochemistry","volume":"425","author":"Merched","year":"1998","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib127","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3233\/JAD-201443","article-title":"Serum levels of clusterin, PKR, and RAGE correlate with amyloid burden in Alzheimer\u2019s disease","volume":"80","author":"Monllor","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"7806","key":"10.1016\/j.arr.2022.101654_bib128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.arr.2022.101654_bib129","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","article-title":"Inflammatory biomarkers in Alzheimer\u2019s disease plasma","volume":"15","author":"Morgan","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum","volume":"144","author":"Moscoso","year":"2021","journal-title":"Brain"},{"issue":"7691","key":"10.1016\/j.arr.2022.101654_bib131","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.arr.2022.101654_bib132","doi-asserted-by":"crossref","first-page":"46","DOI":"10.12703\/r\/10-46","article-title":"Neurofilament light: a narrative review on biomarker utility","volume":"10","author":"Narayanan","year":"2021","journal-title":"Fac. Rev."},{"key":"10.1016\/j.arr.2022.101654_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2021.07.001","article-title":"Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer\u2019s disease dementia","volume":"107","author":"Naud\u00e9","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.arr.2022.101654_bib134","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1021\/acs.jproteome.1c00424","article-title":"Multiplex mass spectrometry analysis of amyloid proteins in human plasma for Alzheimer\u2019s disease diagnosis","volume":"20","author":"Ni","year":"2021","journal-title":"J. Proteome Res"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib135","article-title":"Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer\u2019s disease","volume":"13","author":"Nilsson","year":"2021","journal-title":"Alzheimers Dement (Amst. )"},{"issue":"6","key":"10.1016\/j.arr.2022.101654_bib136","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jnen\/nlaa025","article-title":"The Alzheimer disease-causing presenilin-1 L435F mutation causes increased production of soluble A\u03b243 species in patient-derived iPSC-neurons, closely mimicking matched patient brain tissue","volume":"79","author":"Oakley","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2022.101654_bib137","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab166","article-title":"Plasma amyloid-\u03b2 ratios in autosomal dominant Alzheimer\u2019s disease: the influence of genotype","author":"O\u2019Connor","year":"2021","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.arr.2022.101654_bib138","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/pr5006058","article-title":"Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer\u2019s disease and frontotemporal lobar degeneration","volume":"13","author":"Oeckl","year":"2014","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib139","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1021\/acs.jproteome.9b00824","article-title":"Targeted mass spectrometry suggests beta-synuclein as synaptic blood marker in Alzheimer\u2019s disease","volume":"19","author":"Oeckl","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.arr.2022.101654_bib140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2018.11.038","article-title":"A novel ELISA for the measurement of cerebrospinal fluid SNAP-25 in patients with Alzheimer\u2019s disease","volume":"420","author":"\u00d6hrfelt","year":"2019","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib141","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/glia.20967","article-title":"Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease","volume":"58","author":"Olabarria","year":"2010","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib142","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/acssensors.9b02463","article-title":"Early diagnosis of Alzheimer\u2019s disease in blood using a disposable electrochemical microfluidic platform","volume":"5","author":"de Oliveira","year":"2020","journal-title":"ACS Sens."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib143","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-020-00750-y","article-title":"ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study","volume":"13","author":"Oliveira Monteiro","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib144","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3233\/JAD-210144","article-title":"Heterogeneity of cerebrospinal fluid biomarkers profiles in individuals with distinct levels of cognitive decline: a cross-sectional study","volume":"81","author":"Pais","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.arr.2022.101654_bib146","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Mol. Med"},{"issue":"8","key":"10.1016\/j.arr.2022.101654_bib147","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib148","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awy347","article-title":"Plasma tau\/amyloid-\u03b21-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease","volume":"142","author":"Park","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib149","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.1038\/s41598-020-64461-y","article-title":"SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer\u2019s disease","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.arr.2022.101654_bib150","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1001\/archneur.58.12.2025","article-title":"Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline","volume":"58","author":"Parvathy","year":"2001","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib151","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes","volume":"76","author":"Pase","year":"2019","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.arr.2022.101654_bib152","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14789450.2021.1950536","article-title":"Mass spectrometry-based clinical proteomics - a revival","volume":"18","author":"Pauwels","year":"2021","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.arr.2022.101654_bib153","article-title":"Biological significance of the protein changes occurring in the cerebrospinal fluid of Alzheimer\u2019s disease patients: getting clues from proteomic studies","volume":"11","author":"Pedrero-Prieto","year":"2021"},{"key":"10.1016\/j.arr.2022.101654_bib154","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/brain\/awaa395","article-title":"Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052416","article-title":"ADAM10 plasma and CSF levels are increased in mild Alzheimer\u2019s disease","volume":"22","author":"Pereira Vatanabe","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"5 Suppl","key":"10.1016\/j.arr.2022.101654_bib157","first-page":"S425","article-title":"Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease","volume":"10","author":"Perneczky","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib158","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s12325-019-01212-0","article-title":"Alzheimer\u2019s diagnosis: real-world physician behavior across countries","volume":"37","author":"Podhorna","year":"2020","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib159","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000503105","article-title":"Association between use of statin and risk of dementia: a meta-analysis of observational studies","volume":"54","author":"Poly","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"7","key":"10.1016\/j.arr.2022.101654_bib160","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00259-020-05152-8","article-title":"Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts","volume":"48","author":"Provost","year":"2021","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib161","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer\u2019s disease: implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.arr.2022.101654_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185777","article-title":"Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants","volume":"12","author":"Rehker","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.arr.2022.101654_bib163","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The global deterioration scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib164","first-page":"53","article-title":"Practical detection of a definitive biomarker panel for Alzheimer\u2019s disease; comparisons between matched plasma and cerebrospinal fluid","volume":"5","author":"Richens","year":"2014","journal-title":"Int J. Mol. Epidemiol. Genet"},{"issue":"9080","key":"10.1016\/j.arr.2022.101654_bib165","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0140-6736(05)62568-8","article-title":"Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase","volume":"350","author":"Riemenschneider","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib166","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archneurol.2011.642","article-title":"Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations","volume":"69","author":"Ringman","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101654_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117537","article-title":"Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia","volume":"427","author":"Romagnoli","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib168","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40478-021-01187-6","article-title":"A\u03b243 aggregates exhibit enhanced prion-like seeding activity in mice","volume":"9","author":"Ruiz-Riquelme","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2022.101654_bib169","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neurobiolaging.2021.02.026","article-title":"Amyloid-\u03b2 positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume","volume":"104","author":"S\u00e1nchez-Benavides","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","article-title":"Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology","volume":"15","author":"Sandelius","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101654_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.631770","article-title":"The impact of disease comorbidities in Alzheimer\u2019s disease","volume":"13","author":"Santiago","year":"2021","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib172","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(98)00889-1","article-title":"Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer\u2019s disease","volume":"259","author":"Scacchi","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.arr.2022.101654_bib173","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6740","key":"10.1016\/j.arr.2022.101654_bib174","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JAD-181152","article-title":"Cerebrospinal fluid and plasma biomarkers in neurodegenerative diseases","volume":"68","author":"Seino","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"5594","key":"10.1016\/j.arr.2022.101654_bib176","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib177","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13195-018-0448-x","article-title":"A two-step immunoassay for the simultaneous assessment of A\u03b238, A\u03b240 and A\u03b242 in human blood plasma supports the A\u03b242\/A\u03b240 ratio as a promising biomarker candidate of Alzheimer\u2019s disease","volume":"10","author":"Shahpasand-Kroner","year":"2018","journal-title":"Alzheimers Res Ther."},{"issue":"11","key":"10.1016\/j.arr.2022.101654_bib178","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jalz.2018.07.220","article-title":"Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease","volume":"14","author":"Shaw","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib179","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.arr.2022.101654_bib180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopsych.2017.02.007","article-title":"Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer\u2019s Disease Dementia in Individuals With Mild Cognitive Impairment","volume":"83","author":"Shen","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.arr.2022.101654_bib181","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jalz.2019.06.4951","article-title":"Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay","volume":"15","author":"Shi","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib182","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3233\/JAD-200208","article-title":"Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer\u2019s Disease Pathology","volume":"77","author":"Shi","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101654_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12322","article-title":"Replication study of plasma proteins relating to Alzheimer's pathology","author":"Shi","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101654_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101654_bib185","article-title":"Ceruloplasmin\/Transferrin ratio changes in Alzheimer\u2019s disease","volume":"2011","author":"Squitti","year":"2010","journal-title":"Int J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib186","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.arr.2022.101654_bib187","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012921","article-title":"Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in A\u03b2 pathology are detected","volume":"12","author":"Su\u00e1rez-Calvet","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib188","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)13394-8","article-title":"Increased plasma apolipoprotein E (apoE) levels in Alzheimer\u2019s disease","volume":"223","author":"Taddei","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"21","key":"10.1016\/j.arr.2022.101654_bib189","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1074\/jbc.RA120.012542","article-title":"Knock-in rats with homozygous","volume":"295","author":"Tambini","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2022.101654_bib190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2010.09.073","article-title":"Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease","volume":"1362","author":"Thorsell","year":"2010","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.arr.2022.101654_bib191","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/alzrt266","article-title":"\"Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment","volume":"6","author":"Toledo","year":"2014","journal-title":"Alzheimers Res Ther."},{"issue":"11","key":"10.1016\/j.arr.2022.101654_bib192","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s11910-014-0498-9","article-title":"The relationship between amyloid deposition, neurodegeneration, and cognitive decline in dementia","volume":"14","author":"Vandenberghe","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib193","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s40478-021-01245-z","article-title":"Importance of extracellular vesicle secretion at the blood-cerebrospinal fluid interface in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Vandendriessche","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib194","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2666-7568(20)30061-1","article-title":"Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study","volume":"2","author":"Verberk","year":"2021","journal-title":"Lancet Healthy Longev."},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib195","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/alz.12228","article-title":"Plasma \u03b2-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD","volume":"17","author":"Vergallo","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"35","key":"10.1016\/j.arr.2022.101654_bib196","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis. detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.arr.2022.101654_bib197","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1523\/JNEUROSCI.5077-10.2011","article-title":"Robust amyloid clearance in a mouse model of Alzheimer\u2019s disease provides novel insights into the mechanism of amyloid-beta immunotherapy","volume":"31","author":"Wang","year":"2011","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib198","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","article-title":"Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer\u2019s disease","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.arr.2022.101654_bib199","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3233\/JAD-170786","article-title":"Medical comorbidity in Alzheimer\u2019s disease: a nested case-control study","volume":"63","author":"Wang","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2022.101654_bib201","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fnmol.2018.00216","article-title":"Brain energy and oxygen metabolism: emerging role in normal function and disease","volume":"11","author":"Watts","year":"2018","journal-title":"Front Mol. Neurosci."},{"issue":"Pt 9","key":"10.1016\/j.arr.2022.101654_bib202","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/brain\/awf205","article-title":"Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis","volume":"125","author":"Wei","year":"2002","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.arr.2022.101654_bib203","doi-asserted-by":"crossref","first-page":"a006171","DOI":"10.1101\/cshperspect.a006171","article-title":"The neuropsychological profile of Alzheimer disease","volume":"2","author":"Weintraub","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.arr.2022.101654_bib204","first-page":"7","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","author":"Weller","year":"2018","journal-title":"F1000Res"},{"issue":"9","key":"10.1016\/j.arr.2022.101654_bib205","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to Alzheimer disease","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib206","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/JAD-190434","article-title":"Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer\u2019s disease multimodal biomarker discovery cohort","volume":"74","author":"Westwood","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.arr.2022.101654_bib207","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/nm.3736","article-title":"Alzheimer\u2019s Disease Genetics Consortium. A rare mutation in UNC5C predisposes to late-onset Alzheimer\u2019s disease and increases neuronal cell death","volume":"20","author":"Wetzel-Smith","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib208","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","article-title":"Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease","volume":"7","author":"Whelan","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2022.101654_bib209","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/CIA.S294756","article-title":"Application of Cerebrospinal Fluid AT(N) Framework on the Diagnosis of AD and Related Cognitive Disorders in Chinese Han Population","volume":"16","author":"Ye","year":"2021","journal-title":"Clin. Inter. Aging"},{"issue":"1\u20132","key":"10.1016\/j.arr.2022.101654_bib210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000073981","article-title":"Association between statin use and Alzheimer\u2019s disease","volume":"23","author":"Zamrini","year":"2004","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib211","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-021-00430-x","article-title":"Moving fluid biomarkers for Alzheimer\u2019s disease from research tools to routine clinical diagnostics","volume":"16","author":"Zetterberg","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"8","key":"10.1016\/j.arr.2022.101654_bib212","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","article-title":"Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease","volume":"65","author":"Zetterberg","year":"2008","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2022.101654_bib213","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-020-00754-8","article-title":"Association between polygenic risk score of Alzheimer\u2019s disease and plasma phosphorylated tau in individuals from the Alzheimer\u2019s Disease Neuroimaging Initiative","volume":"13","author":"Zettergren","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2022.101654_bib214","first-page":"10","article-title":"Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction","author":"Zhang","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.arr.2022.101654_bib215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neubiorev.2019.04.014","article-title":"Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis","volume":"102","author":"Zhao","year":"2019","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.arr.2022.101654_bib216","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-016-0054-4","article-title":"The dual roles of cytokines in Alzheimer\u2019s disease: update on interleukins, TNF-\u03b1, TGF-\u03b2 and IFN-\u03b3","volume":"5","author":"Zheng","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2022.101654_bib217","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12014-020-09285-8","article-title":"Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease","volume":"17","author":"Zhou","year":"2020","journal-title":"Clin. Proteom."},{"issue":"6","key":"10.1016\/j.arr.2022.101654_bib218","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.ajpath.2013.01.053","article-title":"A\u03b243 is the earliest-depositing A\u03b2 species in APP transgenic mouse brain and is converted to A\u03b241 by two active domains of ACE","volume":"182","author":"Zou","year":"2013","journal-title":"Am. J. Pathol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:02:59Z","timestamp":1761591779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163722000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":218,"alternative-id":["S1568163722000964"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2022.101654","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new generation of AD biomarkers: 2019 to 2021","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2022.101654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101654"}}